Cellulose membranes suppress complement activation in patients after hemodialysis
Membranes used for dialysis therapy activate complement. Complement activation is maximal after initiating dialysis and returns to predialysis values by the end of dialysis. No changes in C3 levels have been detected after dialysis. We hypothesized that although C3 levels were unchanged, C3 activity...
Gespeichert in:
Veröffentlicht in: | American journal of kidney diseases 2001-08, Vol.38 (2), p.384-389 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 389 |
---|---|
container_issue | 2 |
container_start_page | 384 |
container_title | American journal of kidney diseases |
container_volume | 38 |
creator | Ohi, Hiroyuki Tamano, Mariko Sudo, Sukemasa |
description | Membranes used for dialysis therapy activate complement. Complement activation is maximal after initiating dialysis and returns to predialysis values by the end of dialysis. No changes in C3 levels have been detected after dialysis. We hypothesized that although C3 levels were unchanged, C3 activity could be altered by dialysis. We measured complement activation in vitro in serum from patients randomized to dialysis treatments using different types of membranes. The classical pathway was activated with aggregated immunoglobulin G (IgG), and the alternative pathway was activated with inulin. Both the classical and alternative pathways were suppressed after dialysis using cellulose membranes (aggregate IgG, P [lt ] 0.01; inulin, P [lt ] 0.001). When polyacrylonitrile (PAN) or polyethylene glycol grafted cellulose membranes were used for dialysis, only minor suppression of complement pathways was measured. Levels of the control factor SP-40,40 increased at later times for dialysis using cellulose membranes (P [lt ] 0.05). Factor H levels were also greater after dialysis using cellulose membranes compared with PAN membranes (P [lt ] 0.05). In summary, cellulose membranes suppress complement activation in serum. One suppressing factor may be the complement control factor SP-40,40. [copy ] 2001 by the National Kidney Foundation, Inc. |
doi_str_mv | 10.1053/ajkd.2001.26106 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71050334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0272638601544534</els_id><sourcerecordid>71050334</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-7aea18a85a5f314266da83ffcf8d0ae2b77cfdc1c2a7d129e6ff8c92b62b1bcc3</originalsourceid><addsrcrecordid>eNp1kE1r3DAQhkVpaLZpz70FH0pv3uhjLcnHsKRpIFAKyVmMpRFVaq8djR3Iv4-2u5BccppheOZl5mHsm-BrwRt1AQ__wlpyLtZSC64_sJVopKq1VfYjW3FpZK2V1afsM9ED57xVWn9ip0JsTCu0XrE_W-z7pR8JqwGHLsMOqaJlmjISVX4cph4H3M0V-Dk9wZzGXZV21VS6MqUK4oy5-ovDGBL0z5ToCzuJ0BN-PdYzdv_z6m77q779fX2zvbytvTJyrg0gCAu2gSYqsZFaB7AqRh9t4ICyM8bH4IWXYIKQLeoYrW9lp2UnOu_VGftxyJ3y-LggzW5I5Ms35YVxIWeKIK7UpoAXB9DnkShjdFNOA-RnJ7jbW3R7i25v0f23WDbOj9FLN2B45Y_aCvD9CAB56GPR5hO9yTWNbW3B2gOGxcNTwuzIF20eQ8roZxfG9O4NL5SqkKw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71050334</pqid></control><display><type>article</type><title>Cellulose membranes suppress complement activation in patients after hemodialysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ohi, Hiroyuki ; Tamano, Mariko ; Sudo, Sukemasa</creator><creatorcontrib>Ohi, Hiroyuki ; Tamano, Mariko ; Sudo, Sukemasa</creatorcontrib><description>Membranes used for dialysis therapy activate complement. Complement activation is maximal after initiating dialysis and returns to predialysis values by the end of dialysis. No changes in C3 levels have been detected after dialysis. We hypothesized that although C3 levels were unchanged, C3 activity could be altered by dialysis. We measured complement activation in vitro in serum from patients randomized to dialysis treatments using different types of membranes. The classical pathway was activated with aggregated immunoglobulin G (IgG), and the alternative pathway was activated with inulin. Both the classical and alternative pathways were suppressed after dialysis using cellulose membranes (aggregate IgG, P [lt ] 0.01; inulin, P [lt ] 0.001). When polyacrylonitrile (PAN) or polyethylene glycol grafted cellulose membranes were used for dialysis, only minor suppression of complement pathways was measured. Levels of the control factor SP-40,40 increased at later times for dialysis using cellulose membranes (P [lt ] 0.05). Factor H levels were also greater after dialysis using cellulose membranes compared with PAN membranes (P [lt ] 0.05). In summary, cellulose membranes suppress complement activation in serum. One suppressing factor may be the complement control factor SP-40,40. [copy ] 2001 by the National Kidney Foundation, Inc.</description><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/ajkd.2001.26106</identifier><identifier>PMID: 11479166</identifier><language>eng</language><publisher>Orlando, FL: Elsevier Inc</publisher><subject>Acrylic Resins - pharmacology ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Cellulose - pharmacology ; Clusterin ; Complement Activation - drug effects ; Complement C3 - metabolism ; Complement Factor H - analysis ; Complement Inactivator Proteins - analysis ; Emergency and intensive care: renal failure. Dialysis management ; Glycoproteins - analysis ; Humans ; Immunoglobulin G - pharmacology ; Intensive care medicine ; Inulin - pharmacology ; Medical sciences ; Membranes, Artificial ; Middle Aged ; Molecular Chaperones - analysis ; Renal Dialysis ; Reproducibility of Results</subject><ispartof>American journal of kidney diseases, 2001-08, Vol.38 (2), p.384-389</ispartof><rights>2001 The National Kidney Foundation, Inc.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-7aea18a85a5f314266da83ffcf8d0ae2b77cfdc1c2a7d129e6ff8c92b62b1bcc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0272638601544534$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1075898$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11479166$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohi, Hiroyuki</creatorcontrib><creatorcontrib>Tamano, Mariko</creatorcontrib><creatorcontrib>Sudo, Sukemasa</creatorcontrib><title>Cellulose membranes suppress complement activation in patients after hemodialysis</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><description>Membranes used for dialysis therapy activate complement. Complement activation is maximal after initiating dialysis and returns to predialysis values by the end of dialysis. No changes in C3 levels have been detected after dialysis. We hypothesized that although C3 levels were unchanged, C3 activity could be altered by dialysis. We measured complement activation in vitro in serum from patients randomized to dialysis treatments using different types of membranes. The classical pathway was activated with aggregated immunoglobulin G (IgG), and the alternative pathway was activated with inulin. Both the classical and alternative pathways were suppressed after dialysis using cellulose membranes (aggregate IgG, P [lt ] 0.01; inulin, P [lt ] 0.001). When polyacrylonitrile (PAN) or polyethylene glycol grafted cellulose membranes were used for dialysis, only minor suppression of complement pathways was measured. Levels of the control factor SP-40,40 increased at later times for dialysis using cellulose membranes (P [lt ] 0.05). Factor H levels were also greater after dialysis using cellulose membranes compared with PAN membranes (P [lt ] 0.05). In summary, cellulose membranes suppress complement activation in serum. One suppressing factor may be the complement control factor SP-40,40. [copy ] 2001 by the National Kidney Foundation, Inc.</description><subject>Acrylic Resins - pharmacology</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Cellulose - pharmacology</subject><subject>Clusterin</subject><subject>Complement Activation - drug effects</subject><subject>Complement C3 - metabolism</subject><subject>Complement Factor H - analysis</subject><subject>Complement Inactivator Proteins - analysis</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Glycoproteins - analysis</subject><subject>Humans</subject><subject>Immunoglobulin G - pharmacology</subject><subject>Intensive care medicine</subject><subject>Inulin - pharmacology</subject><subject>Medical sciences</subject><subject>Membranes, Artificial</subject><subject>Middle Aged</subject><subject>Molecular Chaperones - analysis</subject><subject>Renal Dialysis</subject><subject>Reproducibility of Results</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1r3DAQhkVpaLZpz70FH0pv3uhjLcnHsKRpIFAKyVmMpRFVaq8djR3Iv4-2u5BccppheOZl5mHsm-BrwRt1AQ__wlpyLtZSC64_sJVopKq1VfYjW3FpZK2V1afsM9ED57xVWn9ip0JsTCu0XrE_W-z7pR8JqwGHLsMOqaJlmjISVX4cph4H3M0V-Dk9wZzGXZV21VS6MqUK4oy5-ovDGBL0z5ToCzuJ0BN-PdYzdv_z6m77q779fX2zvbytvTJyrg0gCAu2gSYqsZFaB7AqRh9t4ICyM8bH4IWXYIKQLeoYrW9lp2UnOu_VGftxyJ3y-LggzW5I5Ms35YVxIWeKIK7UpoAXB9DnkShjdFNOA-RnJ7jbW3R7i25v0f23WDbOj9FLN2B45Y_aCvD9CAB56GPR5hO9yTWNbW3B2gOGxcNTwuzIF20eQ8roZxfG9O4NL5SqkKw</recordid><startdate>20010801</startdate><enddate>20010801</enddate><creator>Ohi, Hiroyuki</creator><creator>Tamano, Mariko</creator><creator>Sudo, Sukemasa</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010801</creationdate><title>Cellulose membranes suppress complement activation in patients after hemodialysis</title><author>Ohi, Hiroyuki ; Tamano, Mariko ; Sudo, Sukemasa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-7aea18a85a5f314266da83ffcf8d0ae2b77cfdc1c2a7d129e6ff8c92b62b1bcc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Acrylic Resins - pharmacology</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Cellulose - pharmacology</topic><topic>Clusterin</topic><topic>Complement Activation - drug effects</topic><topic>Complement C3 - metabolism</topic><topic>Complement Factor H - analysis</topic><topic>Complement Inactivator Proteins - analysis</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Glycoproteins - analysis</topic><topic>Humans</topic><topic>Immunoglobulin G - pharmacology</topic><topic>Intensive care medicine</topic><topic>Inulin - pharmacology</topic><topic>Medical sciences</topic><topic>Membranes, Artificial</topic><topic>Middle Aged</topic><topic>Molecular Chaperones - analysis</topic><topic>Renal Dialysis</topic><topic>Reproducibility of Results</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohi, Hiroyuki</creatorcontrib><creatorcontrib>Tamano, Mariko</creatorcontrib><creatorcontrib>Sudo, Sukemasa</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohi, Hiroyuki</au><au>Tamano, Mariko</au><au>Sudo, Sukemasa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cellulose membranes suppress complement activation in patients after hemodialysis</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2001-08-01</date><risdate>2001</risdate><volume>38</volume><issue>2</issue><spage>384</spage><epage>389</epage><pages>384-389</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><abstract>Membranes used for dialysis therapy activate complement. Complement activation is maximal after initiating dialysis and returns to predialysis values by the end of dialysis. No changes in C3 levels have been detected after dialysis. We hypothesized that although C3 levels were unchanged, C3 activity could be altered by dialysis. We measured complement activation in vitro in serum from patients randomized to dialysis treatments using different types of membranes. The classical pathway was activated with aggregated immunoglobulin G (IgG), and the alternative pathway was activated with inulin. Both the classical and alternative pathways were suppressed after dialysis using cellulose membranes (aggregate IgG, P [lt ] 0.01; inulin, P [lt ] 0.001). When polyacrylonitrile (PAN) or polyethylene glycol grafted cellulose membranes were used for dialysis, only minor suppression of complement pathways was measured. Levels of the control factor SP-40,40 increased at later times for dialysis using cellulose membranes (P [lt ] 0.05). Factor H levels were also greater after dialysis using cellulose membranes compared with PAN membranes (P [lt ] 0.05). In summary, cellulose membranes suppress complement activation in serum. One suppressing factor may be the complement control factor SP-40,40. [copy ] 2001 by the National Kidney Foundation, Inc.</abstract><cop>Orlando, FL</cop><pub>Elsevier Inc</pub><pmid>11479166</pmid><doi>10.1053/ajkd.2001.26106</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0272-6386 |
ispartof | American journal of kidney diseases, 2001-08, Vol.38 (2), p.384-389 |
issn | 0272-6386 1523-6838 |
language | eng |
recordid | cdi_proquest_miscellaneous_71050334 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Acrylic Resins - pharmacology Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Cellulose - pharmacology Clusterin Complement Activation - drug effects Complement C3 - metabolism Complement Factor H - analysis Complement Inactivator Proteins - analysis Emergency and intensive care: renal failure. Dialysis management Glycoproteins - analysis Humans Immunoglobulin G - pharmacology Intensive care medicine Inulin - pharmacology Medical sciences Membranes, Artificial Middle Aged Molecular Chaperones - analysis Renal Dialysis Reproducibility of Results |
title | Cellulose membranes suppress complement activation in patients after hemodialysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A57%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cellulose%20membranes%20suppress%20complement%20activation%20in%20patients%20after%20hemodialysis&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Ohi,%20Hiroyuki&rft.date=2001-08-01&rft.volume=38&rft.issue=2&rft.spage=384&rft.epage=389&rft.pages=384-389&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/ajkd.2001.26106&rft_dat=%3Cproquest_cross%3E71050334%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71050334&rft_id=info:pmid/11479166&rft_els_id=S0272638601544534&rfr_iscdi=true |